Announcements Trials

Browse Landscape

Status

Recruiting 2348 Active not recruiting 1110 Not yet recruiting 576 Completed 518 Terminated 110 Enrolling by invitation 72 Suspended 67 Withdrawn 36 Available 13 Temporarily not available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

telisotuzumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Temporarily not available × 30 days × Clear all

NCT04830202 2026-05-13

Expanded Access to Telisotuzumab Vedotin

AbbVie

Temporarily not available

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡